Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    ART-123
Show Display Options
Rank Status Study
1 Unknown  Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
Condition: Disseminated Intravascular Coagulation
Intervention: Drug: ART-123
2 Recruiting Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Conditions: Severe Sepsis;   Coagulopathy
Interventions: Drug: ART-123;   Drug: Placebo
3 Completed Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
Conditions: Sepsis;   Disseminated Intravascular Coagulation
Interventions: Drug: ART-123;   Drug: placebo
4 Withdrawn Study to Look at the Effects of ART-123 on Patients With Sepsis and Disseminated Intravascular Coagulation (DIC)
Conditions: Disseminated Intravascular Coagulation;   Sepsis
Interventions: Drug: ART-123;   Drug: placebo
5 Unknown  PI Vs. NNRTI Based Therapy for HIV Advanced Disease
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: zidovudine+lamivudine+lopinavir/ritonavir;   Drug: zidovudine + lamivudine + efavirenz
6 Recruiting The Effect of Laser-assisted Zona Thinning on the Implantation Rate in the Women of Advanced Age
Condition: Female Urogenital Diseases
Intervention: Device: ZILOS-TK IVOS Analyzer

Indicates status has not been verified in more than two years